Yttrium-90 superiority in hepatocellular carcinoma downstaging: Treatment effect or selection bias? Han J, Zhao Y, Zhao J. Hepatology 2025 Oct 28. doi: 10.1097/HEP.0000000000001579.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han J, Zhao Y, Zhao J. Yttrium-90 superiority in hepatocellular carcinoma downstaging: Treatment effect or selection bias? Hepatology 2025 Oct 28. doi: 10.1097/HEP.0000000000001579.
PMID: 41150883